19 天前 - … cell therapies (ICTs) has begun to offer a promising approach to treating a variety of
peripheral blood diseases … be readily differentiated from patient-derived induced pluripotent …

24 天前 - … embryonic stem cells, despite having high differentiation … disease, kidney
transplantation is an effective treatment; … Therefore, stem cell replacement therapy has emerged as …

26 天前 - … pluripotent stem cells (IPSCs) and directed differentiation. … discussed applications
of stem cell therapy for treating … , eye diseases, skin disorders, neurodegenerative diseases …

33 天前 - … Enzyme replacement therapy for lysosomal diseases: … technologies in human
pluripotent stem cells. Gene … development and differentiation of neural crest-derived pigment cells. …

36 天前 - … pluripotent stem (iPS) cells, which can be differentiated to resemble the human
heart in terms of structure, function and cellular … -derived progenitor cells can differentiate into …

36 天前 - … treatment to halt or delay the progression of the disease. … (OCs) from human
induced pluripotent stem cells (iPSCs). This … The differentiation of human iPSCs to OCs is also …

38 天前 - … promise for patients with diseases for which there are few treatments or no cures.
Pluripotent stem cells (PSCs) are at the forefront of these therapeutic strategies. PSCs serve …

101 天前 - … generation of induced pluripotent stem cells and subsequent differentiation to
different … around their application to generate patient-specific cardiac disease models and …

104 天前 - … therapies pose significant challenges. The production of differentiated β cells from
induced pluripotent stem cells … iPSC into cells representative of three relevant disease models…

109 天前 - … (such as heart failure, macular degeneration, type 1 diabetes, or Parkinson’s disease,
… iPSC-derived differentiated cells have great potential for cell replacement therapy even …